Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cassie Goedken"'
Autor:
Alexandre Marra, Gosia Clore, Erin Balkenende, Cassie Goedken, Daniel Livorsi, Michihiko Goto, Vaughan-Sarrazin, Ann Broderick, Eli Perencevich
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2, Pp s19-s20 (2022)
Background: Antibiotic use during end-of-life (EOL) care is an increasingly important target for antimicrobial stewardship given the high prevalence of antibiotic use in this setting with limited evidence on safety and effectiveness to guide antibiot
Externí odkaz:
https://doaj.org/article/7af884568dd64de5ad283439b392e42f
Autor:
Erin Balkenende, Cassie Goedken, Daniel Livorsi, Karleen Giannitrapani, Matthew McCaa, Eli Perencevich
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2, Pp s24-s24 (2022)
Background: Antimicrobials are frequently used during end-of-life care and may be prescribed without a clear clinical indication. Overuse of antimicrobials is a major public health concern because of the development of multidrug resistant organisms (
Externí odkaz:
https://doaj.org/article/dd81df87d1de4a6b99c0828d2716ec4d
Autor:
Stacey Hockett Sherlock, Cassie Goedken, Erin C Balkenende, Kimberly Dukes, Eli N Perencevich, Heather Schacht Reisinger, Marin L Schweizer
Publikováno v:
Open Forum Infectious Diseases. 8:S500-S500
Background Staphylococcus aureus surgical site infection (SSI) is common and devastating clinically. Pre-operative decolonization is associated with reduced incidence, but has been variably adopted due to barriers implementing high-efficacy preventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea4da49498d474f2cf200ba7260fcc8f
https://doi.org/10.1093/ofid/ofab466.1009
https://doi.org/10.1093/ofid/ofab466.1009
Autor:
Cassie Goedken, Marylou Guihan, Charnetta R Brown, Swetha Ramanathan, Amanda Vivo, Margaret A Fitzpatrick, Eli N Perencevich, Michael Rubin, Heather Reisinger, Katie J Suda, Martin Evans, Charlesnika T Evans
Publikováno v:
Open Forum Infectious Diseases
Background Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing (CP) CRE are difficult to treat, resulting in a high mortality annually. In 2017, VA released guidelines for CRE/CP-CRE laboratory testing, prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57db9089bf0632730176559e1d9e07a
http://europepmc.org/articles/PMC6810954
http://europepmc.org/articles/PMC6810954